MedPath

Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography

Phase 4
Conditions
Contrast Induced Nephropathy
Interventions
Registration Number
NCT00950079
Lead Sponsor
CardioVascular Research Foundation, Korea
Brief Summary

The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary angiography or intervention.

Detailed Description

Contrast induced nephropathy (CIN) is a common cause of renal failure associated with prolonged hospitalization, significant morbidity or mortality, and cost. CIN has been reported to account for 10% of hospital acquired renal failure. Several strategies or medications were tried to prevent CIN. Of these, mucomyst and normal saline infusion are effective to prevent CIN. Sodium bicarbonate has shown mixed results from recent randomized trials. Moreover,limited data have been available for preventing CIN in diabetic renal dysfunction undergoing coronary angiography or intervention. Our hypothesis is that addition of sodium bicarbonate will be more efficacious than normal saline in preventing CIN at above situation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
368
Inclusion Criteria
  • age>18 years, no upper limits
  • diabetes treated with insulin or oral hypoglycemic agents
  • serum creatinine >=1.1 and
  • resting estimated glomerular filtration rate <60ml/min/1.73 square meter
Exclusion Criteria
  • serum creatinine >=8mg/dL
  • resting estimated GFR <15ml/min/1.73 square meter
  • end stage renal disease on hemodialysis
  • multiple myeloma
  • uncontrolled hypertension (systolic BP >160mmHg or diastolic BP>100mmHg)
  • acute myocardial infarction
  • emergent coronary angioplasty or angiography
  • recent use of contrast within 2 days
  • allergic reaction to contrast
  • pregnancy
  • allergic to following medication : theophylline, dopamine, mannitol, fenoldopam, N-acetylcysteine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Salinesalinesaline infusion
Sodium bicarbonateSodium bicarbonatesodium bicarbonate
Primary Outcome Measures
NameTimeMethod
Incidence of contrast-induced nephropathy24 and 48 hours after angiography or intervention
Secondary Outcome Measures
NameTimeMethod
all-cause mortality30 days to 6 months after index angiography
stroke30 days to 6 months after index angiography
Dialysis30 days after index angiography
Myocardial infarction30 days after index angiography
dialysis30 days to 6 months after index angiography
myocardial infarction30 days to 6 months after index angiography

Trial Locations

Locations (9)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Busan Saint Mary Hospital

🇰🇷

Busan, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Soonchunhyang University Bucheon Hospital

🇰🇷

Bucheon, Korea, Republic of

Soonchunhyang University Hospital, Cheonan

🇰🇷

Cheonan, Korea, Republic of

Kangwon National University Hospital

🇰🇷

Chuncheon, Korea, Republic of

Soonchunhyang University Seoul Hospital

🇰🇷

Seoul, Korea, Republic of

Gangneung Asan Hospital

🇰🇷

Gangneung, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath